These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis. Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933 [TBL] [Abstract][Full Text] [Related]
6. The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy. Kurosaki M; Matsunaga K; Hirayama I; Tanaka T; Sato M; Komatsu N; Umeda N; Hosokawa T; Ueda K; Tsuchiya K; Nakanishi H; Itakura J; Asahina Y; Miyake S; Enomoto N; Izumi N J Hepatol; 2008 May; 48(5):736-42. PubMed ID: 18329125 [TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic hepatitis C in patients with haemophilia: a review of the literature. Posthouwer D; Mauser-Bunschoten EP; Fischer K; Makris M Haemophilia; 2006 Sep; 12(5):473-8. PubMed ID: 16919076 [TBL] [Abstract][Full Text] [Related]
9. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors. Bani-Sadr F; Lapidus N; Bedossa P; De Boever CM; Perronne C; Halfon P; Pol S; Carrat F; Cacoub P; ; Clin Infect Dis; 2008 Mar; 46(5):768-74. PubMed ID: 18248298 [TBL] [Abstract][Full Text] [Related]
10. Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence. Sharma P; Marrero JA; Fontana RJ; Greenson JK; Conjeevaram H; Su GL; Askari F; Sullivan P; Lok AS Liver Transpl; 2007 Aug; 13(8):1100-8. PubMed ID: 17377914 [TBL] [Abstract][Full Text] [Related]
11. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C. Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587 [TBL] [Abstract][Full Text] [Related]
12. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy. Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394 [TBL] [Abstract][Full Text] [Related]
13. Management of chronic hepatitis C. Asselah T; Boyer N; Ripault MP; Martinot M; Marcellin P Minerva Gastroenterol Dietol; 2007 Mar; 53(1):9-23. PubMed ID: 17415342 [TBL] [Abstract][Full Text] [Related]
14. Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirin. Boo I; Fischer AE; Johnson D; Chin R; Giourouki M; Bharadwaj M; Bowden S; Torresi J; Drummer H J Clin Virol; 2007 Aug; 39(4):288-94. PubMed ID: 17569577 [TBL] [Abstract][Full Text] [Related]
15. Managing chronic hepatitis C in relapsers and non-responders. Montalbano M; Kemmer N; Neff GW Minerva Gastroenterol Dietol; 2008 Mar; 54(1):31-47. PubMed ID: 18299666 [TBL] [Abstract][Full Text] [Related]
16. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy. Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649 [TBL] [Abstract][Full Text] [Related]
18. Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study. Cornberg M; Hadem J; Herrmann E; Schuppert F; Schmidt HH; Reiser M; Marschal O; Steffen M; Manns MP; Wedemeyer H J Hepatol; 2006 Feb; 44(2):291-301. PubMed ID: 16360972 [TBL] [Abstract][Full Text] [Related]
19. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715 [TBL] [Abstract][Full Text] [Related]
20. Factors associated with adherence to combination therapy of interferon and ribavirin for patients with chronic hepatitis C: importance of patient's motivation and physician's treatment experience. Tanioka D; Iwasaki Y; Araki Y; Osawa T; Ikeda H; Ando M; Kobashi H; Sakaguchi K; Shiratori Y; Yamamoto K Liver Int; 2009 May; 29(5):721-9. PubMed ID: 19141025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]